VEGFA and age-related macular degeneration: It was further found that the use of this oral vitamin treatment may reduce the frequency of anti-VEGF ocular injections, which are the standard of care in AMD, with stronger outcomes seen when using vitamin therapy, suggesting that reducing homocysteine and retinal venous pressure, alongside anti-VEGF, may be the most effective treatment of neo-vascular AMD [1].